Taiwan's Academic Sinica has synthesized monoclonal antibodies that are able to identify the protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), an important step in the direction of producing a rapid screening reagent for the fast spreading pathogenic virus.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
No injuries reported after runaway bus crashes into Taipei store
11/05/2024 09:41 PM - Society
5 receive jail terms for stealing CPC diesel
11/05/2024 09:34 PM - Business
Foreign investor holdings of Taiwan stocks, deposits reach record high
11/05/2024 08:24 PM - Science & Tech
Taiwan-Japan co-developed satellite 'Onglaisat' launched into space
11/05/2024 07:44 PM - Society
Ex-cop acquitted in fatal shooting of passenger in fleeing car
11/05/2024 07:08 PM